Related content

Association of genetic variants in VEGF-A with clinical recurrence in prostate cancer patients treated with definitive radiotherapy

By Langsenlehner T.   Thurner E.-M.   Renner W.   Gerger A.   Kapp K.S.   Langsenlehner U.  

Strahlentherapie und Onkologie, Vol. 190, Iss. 4, 2014-04 ,pp. : 364-369

Springer Publishing Company

Access to resources Recommend Favorite

Toxicity after Intensity-Modulated, Image-Guided Radiotherapy for Prostate Cancer

By Guckenberger Matthias   Ok Sami   Polat Bülent   Sweeney Reinhart   Flentje Michael  

Strahlentherapie und Onkologie, Vol. 186, Iss. 10, 2010-10 ,pp. : 535-543

Springer Publishing Company

Access to resources Recommend Favorite

The PROCAINA (PROstate CAncer INdication Attitudes) Project (Part I): a survey among Italian radiation oncologists on postoperative radiotherapy in prostate cancer

By Alongi F.   Bari B.   Franco P.   Ciammella P.   Chekrine T.   Livi L.   Jereczek-Fossa B.   Filippi A.  

La radiologia medica, Vol. 118, Iss. 4, 2013-06 ,pp. : 660-678

Springer Publishing Company

Access to resources Recommend Favorite

Time management in radiation oncology: evaluation of time, attendance of medical staff, and resources during radiotherapy for prostate cancer: The DEGRO-QUIRO trial

By Keilholz L.   Willner J.   Thiel H.-J.   Zamboglou N.   Sack H.   Popp W.  

Strahlentherapie und Onkologie, Vol. 190, Iss. 1, 2014-01 ,pp. : 17-25

Springer Publishing Company

Access to resources Recommend Favorite

Efficacy and toxicity of (chemo)radiotherapy for primary subglottic cancer

By Hata M.   Taguchi T.   Koike I.   Nishimura G.   Takahashi M.   Komatsu M.   Sano D.   Odagiri K.   Minagawa Y.   Inoue T.  

Strahlentherapie und Onkologie, Vol. 189, Iss. 1, 2013-01 ,pp. : 26-32

Springer Publishing Company

Access to resources Recommend Favorite